nach oben

Diabetologia

Erschienen in:

01.03.2014 | Article

Infection-related mortality is higher for kidney allograft recipients with pretransplant diabetes mellitus

verfasst von: Manvir K. Hayer, Daniela Farrugia, Irena Begaj, Daniel Ray, Adnan Sharif

Erschienen in: Diabetologia | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The risk of infection-related mortality in kidney allograft recipients with pre-existing diabetes mellitus is unknown. We determined the risk of infection-related mortality after kidney transplantation in a population-based cohort stratified by diagnosis of pre-existing diabetes mellitus.

Methods

We linked data between two national registries (Hospital Episode Statistics and the Office for National Statistics) to select all mortality events after kidney transplantation in England between April 2001 and March 2012. The primary outcome measure was infection-related mortality after transplantation comparing diabetic with non-diabetic recipients.

Results

A total of 19,103 kidney allograft recipients were analysed; 2,968 (15.5%) were known to have diabetes before kidney transplantation. After transplantation, 2,085 deaths (10.9%) occurred (median follow-up 4.4 years [interquartile range 2.2–7.3]), with 434 classified as secondary to infection (20.8% of all deaths). Risk of overall (16.0% vs 10.0%, p < 0.001) and infection-related (3.3% vs 2.1%, p < 0.001) mortality after kidney transplantation was higher for diabetic than non-diabetic recipients, respectively. No cytomegalovirus-related deaths occurred in diabetic recipients compared with 5.7% in non-diabetic recipients (p < 0.007), with a trend towards more unspecified sepsis in diabetic recipients (30.6% vs 22.6%, respectively, p = 0.070). Diabetes at the time of transplantation was an independent risk factor predicting infection-related mortality in kidney allograft recipients after transplantation (HR 1.71 [95% CI 1.36, 2.15], p < 0.001).

Conclusions/interpretation

Infection-related mortality is more common in kidney allograft recipients with pre-existing diabetes mellitus. Further work is required to determine whether attenuated immunosuppression is beneficial for diabetic kidney allograft recipients.

Rich J, Lee JC (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54:2904–2910PubMedCrossRef

Hirsch T, Spielmann M, Zuhaili B et al (2008) Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg 8:2482–2485CrossRef

Rees DA, Alcolado JC (2005) Animal models of diabetes mellitus. Diabet Med 22:359–370PubMedCrossRef

Bach JF (2005) Infections and autoimmune diseases. J Autoimmun 25:74–80PubMedCrossRef

Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912PubMedCrossRef

Muller LM, Gorter KJ, Hak E, Goudzwaard WL et al (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41:281–288PubMedCrossRef

Peleg AY, Weerarathna T, McCarthy JS, Davis TM (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 23:3–13PubMedCrossRef

Bertoni AG, Saydah S, Brancati FL (2001) Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 24(6):1044–1049PubMedCrossRef

Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care 21:1138–1145PubMedCrossRef

10.

Moss SE, Klien R, Klein BEK (1991) Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81:1158–1162PubMedCrossRef

11.

US Renal Data System (2012) USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 59(Suppl 1):e1–e420

12.

Briggs JD (2001) Causes of death after renal transplantation. Nephrol Dial Transplant 16:1545–1549PubMedCrossRef

13.

Koh GC, Peacock SJ, van der Poll T, Wiersinga WJ (2012) The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis 31:379–388

14.

Kato S, Chmielewski M, Honda H et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3:1526–1533PubMedCrossRef

15.

Lansang MC, Ma L, Schold JD, Meier-Kriesche HU, Kaplan B (2006) The relationship between diabetes and infectious hospitalizations in renal transplant recipients. Diabetes Care 29:1659–1660PubMedCrossRef

16.

OPCS-4 classification – NHS Connecting for Health. Available from www.connectingforhealth.nhs.uk. Accessed 12 June 2013

17.

World Health Organization: International Classification of Diseases (ICD). Available from www.who.int/classifications/icd/en. Accessed 5 June 2013

18.

Department for Communities and Local Government. The English Indices of Deprivation 2010. Available from www.gov.uk/government/publications/english-indices-of-deprivation-2010. Accessed17 June 2013

19.

von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457CrossRef

20.

Steenkamp R, Shaw C, Feest T (2013) UK Renal Registry 15th Annual Report: Chapter 5, Survival and causes of death of UK adult patients on renal replacement therapy in 2011: national and centre-specific analyses. Nephron Clin Pract 123(Suppl 1):93–123PubMedCrossRef

21.

Zykova SN, Jenssen TG, Berdal M et al (2000) Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 49:1451–1458PubMedCrossRef

22.

Al-Mashat HA, Kandru S, Liu R et al (2006) Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 55:487–495PubMedCrossRef

23.

Ilyas R, Wallis R, Soilleux EJ et al (2011) High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology 216:126–131PubMedCentralPubMedCrossRef

24.

Price CL, Hassi HO, English NR et al (2010) Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med 14:1806–1815PubMedCrossRef

25.

Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554PubMedCrossRef

26.

Marelli D, Laks H, Patel B et al (2003) Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 22:1091–1097PubMedCrossRef

27.

Thomas MC, Mathew TH, Russ GR et al (2001) Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 72:1321–1324PubMedCrossRef

28.

Kotton CN, Fishman JA (2005) Viral infection in the renal transplant recipient. J Am Soc Nephrol 16:1758–1774PubMedCrossRef

29.

Yoon JW (1990) The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol 164:95–123PubMed

30.

Pak CY, McArthur RG, Eun HM, Yoon JW (1988) Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 332:1–4CrossRef

31.

Hjelmesaeth J, Muller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005) Is there a link between cytomegalovirus infection and new-onset diabetes after transplantation? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant 20:2311–2315PubMedCrossRef

32.

Leung Ki EL, Venetz JP, Meylan P, Lamoth F, Ruiz J, Pascual M (2008) Cytomegalovirus infection and new-onset diabetes after transplantation. Clin Transplant 22:245–249

33.

Sharif A, Baboolal K (2011) Complications of new onset diabetes after kidney transplantation. Nat Rev Nephrol 8:34–42PubMedCrossRef

34.

Benavides FG, Bolumar F, Peris R (1989) Quality of death certificates in Valencia, Spain. Am J Public Health 79:1352–1354PubMedCrossRef

35.

Pinner R, Tetutsh SM, Simonsen L et al (1996) Trends in infectious disease mortality in the United States. JAMA 275:189–193PubMedCrossRef

36.

Kircher T, Nelson J, Burdo H (1985) The autopsy as a measure of accuracy of the death certificate. N Engl J Med 313:1263–1269PubMedCrossRef

37.

Lloyd-Jones DM, Martin DO, Larson MG, Levy D (1998) Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129:1020–1026PubMedCrossRef

Titel: Infection-related mortality is higher for kidney allograft recipients with pretransplant diabetes mellitus
verfasst von: Manvir K. Hayer
Daniela Farrugia
Irena Begaj
Daniel Ray
Adnan Sharif
Publikationsdatum: 01.03.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 3/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-013-3124-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed

Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program

Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model

Erratum to: Genetic associations in diabetic nephropathy: a meta-analysis

A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle

Maternal smoking during pregnancy and the risk of childhood type 1 diabetes in Western Australia